Robert Torray - Torray Investment Partners
Holding/activity history for Vertex Pharmaceuticals (VRTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 15,386 | 1.08 | Reduce 0.52% | <0.01 | $446.54 | $6,870,464 | SEC |
| 2025 Q4 | 15,466 | 1.08 | Reduce 4.85% | 0.04 | $453.36 | $7,011,666 | SEC |
| 2025 Q3 | 16,255 | 0.89 | Reduce 3.70% | 0.04 | $391.64 | $6,366,108 | SEC |
| 2025 Q2 | 16,879 | 1.09 | Add 7.37% | 0.07 | $445.20 | $7,514,531 | SEC |
| 2025 Q1 | 15,721 | 1.14 | Reduce 1.79% | 0.02 | $484.82 | $7,621,855 | SEC |
| 2024 Q4 | 16,008 | 0.92 | Add 1.63% | 0.01 | $402.70 | $6,446,422 | SEC |
| 2024 Q3 | 15,751 | 1.03 | Add 13.01% | 0.12 | $465.08 | $7,325,475 | SEC |
| 2024 Q2 | 13,938 | 0.98 | Add 0.28% | <0.01 | $468.72 | $6,533,019 | SEC |
| 2024 Q1 | 13,899 | 0.87 | Reduce 1.20% | 0.01 | $418.01 | $5,809,921 | SEC |
| 2023 Q4 | 14,068 | 0.93 | Buy | 0.93 | $406.89 | $5,724,129 | SEC |
| 2014 Q2 | 0 | 0.00 | Sell 100.00% | 0.95 | SEC | ||
| 2014 Q1 | 76,397 | 0.95 | Add 40.75% | 0.28 | $70.72 | $5,403,000 | SEC |
| 2013 Q4 | 54,280 | 0.88 | Add 18.08% | 0.13 | $74.30 | $4,033,000 | SEC |
| 2013 Q3 | 45,970 | 0.79 | Add 1.32% | 0.01 | $75.81 | $3,485,000 | SEC |
| 2013 Q2 | 45,372 | 0.84 | Reduce 39.47% | 0.38 | $80.05 | $3,632,000 | SEC |
| 2013 Q1 | 74,960 | 0.95 | Add 2.59% | 0.02 | $54.98 | $4,121,000 | SEC |
| 2012 Q4 | 73,069 | 0.76 | Add 45.36% | 0.24 | $41.91 | $3,062,000 | SEC |
| 2012 Q3 | 50,268 | 0.65 | Add 13.98% | 0.08 | $55.88 | $2,809,000 | SEC |
| 2012 Q2 | 44,103 | 0.59 | Reduce 16.23% | 0.08 | $55.91 | $2,466,000 | SEC |
| 2012 Q1 | 52,645 | 0.50 | Buy | 0.50 | $41.01 | $2,159,000 | SEC |